Category: Life Sciences
Life Sciences market research reports by Plunkett Research, Ltd.
-
Incyte Corporation (INCY:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Incyte Corporation (INCY:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Incyte Corporation (INCY:NAS) compared to its top competitors and compared to the ... Read More
-
Recursion Pharmaceuticals Inc (RXRX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Recursion Pharmaceuticals Inc (RXRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Recursion Pharmaceuticals Inc (RXRX:NAS) compared to its top competitor ... Read More
-
Spectrum Pharmaceuticals Inc (SPPI:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Spectrum Pharmaceuticals Inc (SPPI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Spectrum Pharmaceuticals Inc (SPPI:NAS) compared to its top competitors ... Read More
-
BioCryst Pharmaceuticals Inc (BCRX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
BioCryst Pharmaceuticals Inc (BCRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for BioCryst Pharmaceuticals Inc (BCRX:NAS) compared to its top competitors ... Read More
-
Arrowhead Pharmaceuticals Inc (ARWR:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Arrowhead Pharmaceuticals Inc (ARWR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Arrowhead Pharmaceuticals Inc (ARWR:NAS) compared to its top competitor ... Read More
-
Agenus Inc (AGEN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Agenus Inc (AGEN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Agenus Inc (AGEN:NAS) compared to its top competitors and compared to the average for all ... Read More
-
Ultragenyx Pharmaceutical Inc (RARE:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Ultragenyx Pharmaceutical Inc (RARE:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Ultragenyx Pharmaceutical Inc (RARE:NAS) compared to its top competitor ... Read More
-
Lineage Cell Therapeutics Inc (LCTX:ASE): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Lineage Cell Therapeutics Inc (LCTX:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Lineage Cell Therapeutics Inc (LCTX:ASE) compared to its top competitor ... Read More
-
ADMA Biologics Inc (ADMA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
ADMA Biologics Inc (ADMA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for ADMA Biologics Inc (ADMA:NAS) compared to its top competitors and compared to the ... Read More
-
OSI Systems Inc (OSIS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
OSI Systems Inc (OSIS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for OSI Systems Inc (OSIS:NAS) compared to its top competitors and compared to the averag ... Read More
-
Reata Pharmaceuticals (RETA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Reata Pharmaceuticals (RETA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Reata Pharmaceuticals (RETA:NAS) compared to its top competitors and compared t ... Read More
-
Alnylam Pharmaceuticals Inc (ALNY:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Alnylam Pharmaceuticals Inc (ALNY:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Alnylam Pharmaceuticals Inc (ALNY:NAS) compared to its top competitors an ... Read More
-
Vertex Pharmaceuticals Incorporated (VRTX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Vertex Pharmaceuticals Incorporated (VRTX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Vertex Pharmaceuticals Incorporated (VRTX:NAS) compared to its to ... Read More
-
Amphastar Pharmaceutical Inc (AMPH:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Amphastar Pharmaceutical Inc (AMPH:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Amphastar Pharmaceutical Inc (AMPH:NAS) compared to its top competitors ... Read More
-
Myriad Genetics Inc (MYGN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Myriad Genetics Inc (MYGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Myriad Genetics Inc (MYGN:NAS) compared to its top competitors and compared to th ... Read More
-
Supernus Pharmaceuticals Inc (SUPN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Supernus Pharmaceuticals Inc (SUPN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Supernus Pharmaceuticals Inc (SUPN:NAS) compared to its top competitors ... Read More
-
Celldex Therapeutics Inc (CLDX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Celldex Therapeutics Inc (CLDX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Celldex Therapeutics Inc (CLDX:NAS) compared to its top competitors and comp ... Read More
-
OPKO Health Inc (OPK:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
OPKO Health Inc (OPK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for OPKO Health Inc (OPK:NAS) compared to its top competitors and compared to the average ... Read More
-
Eli Lilly and Company (LLY:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Eli Lilly and Company (LLY:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Eli Lilly and Company (LLY:NYS) compared to its top competitors and compared to ... Read More
-
Exelixis Inc (EXEL:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Exelixis Inc (EXEL:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Exelixis Inc (EXEL:NAS) compared to its top competitors and compared to the average for ... Read More
-
Bristol-Myers Squibb Company (BMY:NYS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Bristol-Myers Squibb Company (BMY:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Bristol-Myers Squibb Company (BMY:NYS) compared to its top competitors an ... Read More
-
Amgen Inc (AMGN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Amgen Inc (AMGN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Amgen Inc (AMGN:NAS) compared to its top competitors and compared to the average for all co ... Read More
-
Paratek Pharmaceuticals Inc (PRTK:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Paratek Pharmaceuticals Inc (PRTK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Paratek Pharmaceuticals Inc (PRTK:NAS) compared to its top competitors an ... Read More
-
RVL Pharmaceuticals PLC (RVLP:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
RVL Pharmaceuticals PLC (RVLP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for RVL Pharmaceuticals PLC (RVLP:NAS) compared to its top competitors and compar ... Read More
-
Curis Inc (CRIS:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
Curis Inc (CRIS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings. This unique new report provides deep financial benchmarks for Curis Inc (CRIS:NAS) compared to its top competitors and compared to the average for all co ... Read More